3,320
edits
Changes
Jump to navigation
Jump to search
→Agonists
* An agonist forms a complex with the receptor. This complex is '''dynamic''' as the agonist will continously dissociate and associate with the receptor. The agonist will continue to do this and thus producing a response, until the concentration of the agonist is reduced to a level at which no tissue response occurs.
* An agonist forms a complex with the receptor. This complex is '''dynamic''' as the agonist will continously dissociate and associate with the receptor. The agonist will continue to do this and thus producing a response, until the concentration of the agonist is reduced to a level at which no tissue response occurs.
* The rate of complex fromation is dependent on two factors: '''agonist concentration''' and the '''number of free receptors'''.
* The rate of complex fromation is dependent on two factors: '''agonist concentration''' and the '''number of free receptors'''.
* The '''affinty''' of a drug to a receptor varies and can be compared using the '''equilinbrum constant or K<sub>A</sub>'''.
* The '''affinty''' of a drug to a receptor varies and can be compared using the '''equilinbrum constant or K<sub>A</sub>'''.
This can be defined as the concentration of a drug which results in 50% of receptors being bound in equilibrium or when K<sub>1</sub>=K<sub>-1</sub>.
This can be defined as the concentration of a drug which results in 50% of receptors being bound in equilibrium or when '''K<sub>1</sub>=K<sub>-1</sub>'''.
<big>'''Drug + Number of Free Receptors = Drug-Receptor Complexes'''</big>
Where '''K<sub>1</sub>''' is the rate constant in a forward direction
and '''K<sub>-1</sub>''' is the rate constant in a backward direction
Therefore a drug that has a higher affinity to a receptor has a lower '''K<sub>A</sub>''' value.